Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Gábor Pogátsa"'
Publikováno v:
Arzneimittelforschung. 52:552-559
The effects of glibenclamide (GB, CAS 10238-21-8) and those of the latest low daily dose sulphonylurea compound, glimepiride (GM, CAS 93479-97-1) on myocardial haemodynamics and pyruvate-lactate metabolism of healthy and alloxan-diabetic dogs (n = 6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::472afc898237ddbc40e1521240884c4b
https://doi.org/10.1055/s-0031-1299929
https://doi.org/10.1055/s-0031-1299929
Publikováno v:
Acta Physiologica Scandinavica. 169:183-187
The aim of the present study was to investigate the effects of experimental diabetes and hyperglycaemia per se on the endothelium-dependent relaxation of isolated canine coronary arteries and to analyse the possible involvement of the cyclooxygenase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b66e97246f1cf42dbe114862039309f
https://doi.org/10.1046/j.1365-201x.2000.00731.x
https://doi.org/10.1046/j.1365-201x.2000.00731.x
Autor:
Gábor Pogátsa
Publikováno v:
Diabetes Research and Clinical Practice. 31:S27-S31
Since the first publication of the University Group Diabetes Programme in 1970 the possible deleterious cardiovascular effects of certain hypoglycaemic sulphonylurea products has been well known. In contrast, international knowledge of the advantageo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bbb8db911af5906e57385be538dcc1e
https://doi.org/10.1016/0168-8227(96)01227-2
https://doi.org/10.1016/0168-8227(96)01227-2
Autor:
Sophie M, Koltai, Erzsébet, Kocsis, Ildikó, Pósa, Pál, Hadházy, György, Jermendy, Gábor, Pogátsa
Publikováno v:
Experimental and clinical cardiology. 7(4)
It is well known that cardiovascular alterations are the principal causes of mortality in patients with diabetes. Premature and accelerated atherosclerosis cannot be the sole cause of diabetic heart disease because functional disorders develop both i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b6a776d89e5f588eb90e44f51f3e1d46
https://pubmed.ncbi.nlm.nih.gov/19644594
https://pubmed.ncbi.nlm.nih.gov/19644594
Publikováno v:
Diabetes Research and Clinical Practice. 11:47-52
The effects of first generation sulphonylurea compounds carbutamide, gliclazide and tolbutamide as well as second generation compounds glibenclamide and glipizide on the cardiovascular system were investigated in dogs. Six dogs received each compound
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38e7f101915a29c0f8ff7bcce4654e67
https://doi.org/10.1016/0168-8227(91)90140-9
https://doi.org/10.1016/0168-8227(91)90140-9
Publikováno v:
Acta Diabetologica Latina. 27:295-301
QT interval alterations were measured in 41 non-insulin-dependent (type 2) diabetic patients and 14 age- and sex-matched control subjects. Cardiac autonomic neuropathy (CAN) was assessed by noninvasive tests (deep breathing, Valsalva maneuver and lyi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53cc0eb2ee157a5cc074adf6175194f2
https://doi.org/10.1007/bf02580933
https://doi.org/10.1007/bf02580933
Publikováno v:
Diabetes Research and Clinical Practice. 8:109-114
The effects of first and second generation hypoglycemic sulfonylureas on the incidence of ventricular ectopic beats and on the duration of transitional ventricular fibrillation in the ischemic rat heart were investigated. First generation sulfonylure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f7ad73afccd720139dbaddd0b18b479
https://doi.org/10.1016/0168-8227(90)90020-t
https://doi.org/10.1016/0168-8227(90)90020-t
Autor:
Gábor, Pogátsa
Publikováno v:
Orvosi hetilap. 144(14)
Theoretical and experimental research data as well as human epidemiological studies on large populations suggest a great difference in influencing cardiovascular processes and alterations among the oral antidiabetic drugs used in the treatment of typ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2f457ab2e708012ba90f3843f6d8f4b6
https://pubmed.ncbi.nlm.nih.gov/12795025
https://pubmed.ncbi.nlm.nih.gov/12795025
Publikováno v:
Experimental and clinical endocrinologydiabetes : official journal, German Society of Endocrinology [and] German Diabetes Association. 110(5)
The sensitivity of the myocardium to ischemia and the level of protection achieved by ischemic preconditioning is shaped by the joint influence of several mechanisms in diabetes mellitus. In vivo studies were made in alloxan diabetic and non-diabetic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f3341bc1f8c913c7d6e7f3d4b55d946
https://pubmed.ncbi.nlm.nih.gov/12148084
https://pubmed.ncbi.nlm.nih.gov/12148084
Autor:
Gábor Pogátsa, Erzsébet Kocsis, Koltai Mz, Ildikó Pósa, Pál Hadházy, Peter Rosen, Gábor Winkler
Publikováno v:
Cardiovascular research. 34(1)
Objective: To study the influence of diabetes on the endothelium-dependent vasodilation in the coronary arterial bed. Methods: The effects of acetylcholine (ACh 2–36 pmol·kg−1; 18 nmol·l−1–9.8 μmol·l−1; 0.1–10 μmol·l−1), l-arginin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff089dbf9dc8a7719be4035e5c2a3c03
https://pubmed.ncbi.nlm.nih.gov/9217885
https://pubmed.ncbi.nlm.nih.gov/9217885